Mesostriatal and mesolimbic dopamine uptake binding sites are reduecd in Parkinson’s disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol.
Chinaglia G, Álvarez FJ, Probst A, Palacios JM (1992). Mesostriatal and mesolimbic dopamine uptake binding sites are reduecd in Parkinson’s disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol. Neuroscience 49(2), 317-327. Enlace